◆ 会议时间:2024年3月8日至12日
◆ 会议地点:美国 圣迭戈(San Diego, Calif.)
◆ 会议简介:
2024年第82届美国皮肤科学会(AAD)年会将于2024年3月8日至12日在美国加利福尼亚州圣迭戈举行。AAD年会是全球皮肤科领域最大最具影响力的国际盛会,每届年会都会吸引来自世界各地的16000余名代表以及400多家参展商参加,AAD年会是您与皮肤科领域最优秀的人才建立联系,协作和分享经验知识的重要平台。
美国皮肤病学会(AAD)成立于1938年,是世界上最大、最具影响力和最具代表性的皮肤科组织。AAD现拥有超过20000名会员,几乎代表了美国所有的执业皮肤科医生以及越来越多的国际皮肤科医生。美国皮肤病学会(AAD)的使命是通过教育、研究和宣宣传提升在皮肤病学领域的领导力和为患者提供卓越的护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).
AAD 2024 - American Academy of Dermatology Association (AAD) Annual Meeting
Date: March 8-12, 2024
Venue: San Diego, Calif., USA
摘要征文投稿:
Access the following information for abstract submissions
Submission timelines and guidelines are subject to change. Visit this page frequently for any updates.
|
Gross & Microscopic Symposium |
Resident & Fellows Symposium |
Poster Exhibits |
Late-breaking Research Abstracts |
Guidelines |
|
|
|
|
Submission
timeline &
links |
|
|
|
|
When |
Friday, March 8 and Saturday, March 9, 2024
9 a.m. - 5 p.m.
|
Saturday,
March 9, 2024
9 a.m. - 12 p.m.
|
Posters will be presented Friday, March 8 and Saturday, March 9, 2024 from
8:30 a.m. - 5 p.m.
and Sunday, March 10, 2024 from
1 p.m. - 3:30 p.m.
|
Saturday, March 9, 2024
9 a.m. - 12 p.m. and
Sunday, March 10, 2024
1 p.m. - 4 p.m |
Target audience |
All members of the Academy, medical
students, residents, fellows, and non-members are eligible to submit. |
Residents &
fellows
**Medical
students are not eligible to submit for this program. |
All members of the Academy, medical students, residents and fellows, and nonmembers are eligible to submit. |
All members of the Academy, medical students, residents and fellows, and nonmembers are eligible to submit. |
Description
|
Studies appropriate for consideration should focus on common diseases with unusual facets or unusual diseases with attendant teaching value. |
Clinical and laboratory research-based abstracts should be submitted.
The top three award recipients in each category will receive a cash reward. (See guidelines for more information.)
** Case-based studies and series are not appropriate for this program and will automatically be excluded from the review process. |
Poster exhibits present new ideas and original observations of scientific information utilizing narrative material, photographs, charts, diagrams, etc.
The highest scoring abstracts will be considered for presentation at the 2023 Annual Meeting.
The primary author of the top five scoring posters will be given certificates of recognition, monetary AAD certificates, and the poster abstract will be published in an online JAAD supplement.
**Case reports that are rare or novel will be considered, however, they are more applicable for the Gross & Microscopic abstract program. |
Researchers are invited to submit abstracts describing their most recent results on the latest ground-breaking observations in clinical, therapeutics, surgical, pediatric, dermatopathologic, and basic research.
New therapies will be given top priority, particularly data from pivotal trials of unapproved drugs or unapproved indications. In addition, novel observations that could be practice-changing will also be given top consideration.
**Case-based studies and series are not appropriate for this program and will automatically be excluded from the review process. |
Notification of acceptance |
Sent via email to primary author late November 2023.
|
Sent via email to primary author late November 2023. |
Sent via email to primary author
early December 2023.
Accepted poster abstract uploads will be due by Jan. 24, 2024.
|
Sent via email to
primary author
late February 2024. |
Abstract release information
Gross & Microscopic Symposium, Late-breaking Research, Poster Exhibits, and Resident & Fellows Symposium abstracts will release only the following information 1-2 weeks prior to the Annual Meeting:
- Abstract title
- Authors
- Presentation date/time
Full abstract content will only be available in-person at the presentation time, not online.
Poster Exhibits: Abstract content will be available in the online viewing portal and on-site at the viewing stations. They will also be published online via the JAAD supplement in Fall 2024.
Late-breaking Research: The full abstract content is embargoed until 7 a.m. PST on Saturday, March 9, at which time they will be released as a handout for the corresponding session. You can find the session information and handouts here.
AAD2024 注册费:
REGISTRATION CATEGORY
|
EARLY BIRD FEE
|
STANDARD FEE
Beginning 1/31/24 at
12:01 p.m. (CT) |
Physician member |
$980 |
$1,175
|
Adjunct member |
$980 |
$1,175 |
Life member |
$310 |
$405 |
Honorary member |
$310 |
$405 |
Resident, medical fellow, and graduate member |
$295 |
$385 |
Medical student |
$115 |
$180 |
Non-member physician
Treating patients in an office-like setting. Day pass for $1,550. Available to only this category, on-site. Can only be purchased on day of use. One per meeting.
|
$2,200 |
$2,650 |
Non-member, non-physician
Non-member corporate individuals, pharmacists, distributors, industry representatives, marketers, business developers, and scientists/researchers, CEO, COO, or Director level titles working in the field of dermatology. This also includes aestheticians/estheticians and cosmetologists and all employees affiliated with aesthetician/esthetician or cosmetologist procedures. |
$2,350 |
$2,825 |
Care team (PA/NP/RN/LPN)
Working in an AAD member dermatologist's office; employing physician does not need to be registered. |
$980 |
$1,175 |
Dermatology practice staff
(See here for category description). Must be employed by practicing dermatologist; employing physician does not need to be registered. |
$980 |
$1,175 |
Guest
Defined as a spouse, significant other, or personal friend who is not an active industry professional. 1 per physician registrant. |
$165 |
$230 |
* Those with a Guest badge will have access to the Plenary and the Exhibit hall on Sunday, March 10 only. Those with an Exhibitor badge will only have access to the Plenary and the Exhibit hall. Meeting registration in an appropriate, alternative category is required to attend any educational sessions.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|